Nabriva Therapeutics PLC (NASDAQ:NBRV)

2.10
Delayed Data
As of Sep 30
 +0.06 / +2.94%
Today’s Change
2.04
Today|||52-Week Range
35.00
-85.97%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2018
Quarter 3
2018
Quarter 4
2018
Quarter 1
2019
AssetsCash75.3M100.3M102.0M91.0M
 
 
 
 
 
Short Term Investment Cash-14.0M24.6M1.5M-11.0M
 
 
 
 
 
Cash & Short Term Investments75.5M100.7M102.2M91.3M
 
 
 
 
 
 
ReceivablesReceivables8.3M8.9M5.4M8.2M
 
 
 
 
 
 
InventoriesInventories0.000.000.000.00--
 
Current AssetsPrepaid Expenses1.2M1.2M1.2M973.0K
 
 
 
 
 
Current Assets84.9M110.7M108.8M100.5M
 
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross----4.6M--
 
 
Depreciation-----3.5M--
 
 
Intangible Assets127.0K109.0K98.0K99.0K
 
 
 
 
 
Other Assets127.0K109.0K98.0K99.0K
 
 
 
 
 
Total Assets86.8M112.4M110.4M104.0M
 
 
 
 
 
 
LiabilitiesAccounts Payable2.9M4.8M3.3M7.6M
 
 
 
 
 
Other Current Liabilities4.6M5.4M7.1M5.9M
 
 
 
 
 
Other Liabilities11.3M15.1M17.8M18.1M
 
 
 
 
 
 
Total LiabilitiesLong Term Debt592.0K710.0K23.7M23.9M
 
 
 
 
 
Other Liabilities236.0K244.0K264.0K1.8M
 
 
 
 
 
Total Liabilities12.1M16.0M41.8M43.9M
 
 
 
 
 
 
EquityMinority Interest0.000.000.000.00--
Preferred Stock0.000.000.000.00--
Common Equity74.7M96.4M68.6M60.1M
 
 
 
 
 
Total Shareholder Equity74.7M96.4M68.6M60.1M
 
 
 
 
 
 
Share InformationCommon Shares Outstanding41.0M66.5M67.0M71.3M
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.